mortality/aging
• die between E11.5 and E13.5
• supplementation with both L-DOPA and sepiapterin improves survival but does not fully rescue
|
cardiovascular system
• at E11.5 in 7 of 12 surviving null mice
|
homeostasis/metabolism
• decrease in L-DOPA levels at E11.5
|